Diabetes Care, Vol 21, Issue 1 38-41, Copyright © 1998 by American Diabetes Association

ARTICLES

Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome

G Valerio, A Franzese, V Poggi and A Tenore
Department of Pediatrics, School of Medicine, University of Udine, Italy.

OBJECTIVE: To describe a 15-year follow-up of diabetes and to present data regarding pancreatic beta-cell function in two adolescents affected by the thiamine-responsive megaloblastic anemia (TRMA) syndrome. CASE REPORTS: The first patient (PMR) is a 17.5-year-old Italian girl who presented megaloblastic anemia at 7.5 months of age. At age 2.5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T). The second patient (PF) is a 16.8-year-old Italian boy born to consanguineous parents. Sensorineural deafness was diagnosed at age 1.5 years, while diabetes with ketoacidosis and megaloblastic anemia were diagnosed at age 3 years. Treatment with thiamine HCl was started immediately after diagnosis and changed to BOM-T 2 months later. Subsequent to the initiation of the vitamin, the two patients did not require insulin for approximately 7 and 10 years, respectively. Puberty was determinant in deteriorating the metabolic control in these patients, leading to treatment with an oral hypoglycemic agent and finally to a reinstitution of insulin therapy. CONCLUSIONS: The hormonal assessment in our patients (normal insulin response to oral glucose in childhood, preserved C-peptide secretion in case 2) and the good response to an oral hypoglycemic agent would indicate that the pancreatic disease may initiate as type 2 diabetes and may progress after several years to an insulin-requiring diabetes, as indicated by the exhaustion of the insulin secretory capacity.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Yesilkaya, A. Bideci, M. Temizkan, Z. Kaya, O. Camurdan, A. Koc, D. Bozkaya, U. Kocak, and P. Cinaz A Novel Mutation in the SLC19A2 Gene in a Turkish Female with Thiamine-responsive Megaloblastic Anemia Syndrome J Trop Pediatr, July 9, 2008; (2008) fmn060v1. [Abstract] [Full Text] [PDF]

				A. Stirban, M. Negrean, B. Stratmann, C. Gotting, J. Salomon, K. Kleesiek, and D. Tschoepe Adiponectin Decreases Postprandially Following a Heat-Processed Meal in Individuals With Type 2 Diabetes: An effect prevented by benfotiamine and cooking method Diabetes Care, October 1, 2007; 30(10): 2514 - 2516. [Full Text] [PDF]

				A. S Alzahrani, E. Baitei, M. Zou, and Y. Shi Thiamine transporter mutation: an example of monogenic diabetes mellitus Eur. J. Endocrinol., December 1, 2006; 155(6): 787 - 792. [Abstract] [Full Text] [PDF]

				K. Oishi, S. Hofmann, G. A. Diaz, T. Brown, D. Manwani, L. Ng, R. Young, H. Vlassara, Y. A. Ioannou, D. Forrest, et al. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice Hum. Mol. Genet., November 1, 2002; 11(23): 2951 - 2960. [Abstract] [Full Text] [PDF]

				V. Villa, A. Rivellese, F. Di Salle, C. Iovine, V. Poggi, and B. Capaldo Acute Ischemic Stroke in a Young Woman with the Thiamine-Responsive Megaloblastic Anemia Syndrome J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 947 - 949. [Full Text]

				P. V. Blair, R. Kobayashi, H. M. Edwards, N. F. Shay, D. H. Baker, and R. A. Harris Dietary Thiamin Level Influences Levels of Its Diphosphate Form and Thiamin-Dependent Enzymic Activities of Rat Liver J. Nutr., March 1, 1999; 129(3): 641 - 648. [Abstract] [Full Text]